Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
about
Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-D-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report.Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infectionDetection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal MeningitisProtective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosinIs Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.Molecular diagnosis of invasive mycoses of the central nervous system.Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.Chronic Invasive Aspergillus Sinusitis and Otitis with Meningeal Extension Successfully Treated with Voriconazole.Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis.Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.Non-cultural methods for the diagnosis of invasive fungal disease.Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1→3)-β-D-glucan.Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.(1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
P2860
Q30376282-F3B664B2-D6E6-4F44-8B0E-6FC00EBFC41FQ33718056-72028D7D-7E32-4280-8CB0-A68FCA6D47DEQ34505582-BF93273F-94A7-408E-A5E8-EA3054B6E414Q34916859-C76C3A68-E289-4DA7-930A-57A76C8C7AFBQ35072106-C8AB4A34-ACAC-4AA5-A26F-B82917330E4BQ35691639-71B5FA90-3362-4D74-97DF-484B29EBD5CFQ36169427-2197C983-66E0-47AE-B2B1-93C8795FD6ADQ36218994-254A711F-236F-4460-B115-8576AE1BFAB0Q36276191-D7F0D6FC-E66C-49A1-ACD6-F64C5F0336C6Q36290477-465DAAA2-8E72-4DD0-84E1-CDC75FAAA169Q36884515-F5B43754-454A-47D2-9B4A-5D7CE103309CQ36887855-8D20BCE9-4ED1-4B4A-AD71-2D833E11C30CQ37463387-63E7E982-1C84-4948-B792-D729E7DF75E7Q37829260-2287FBBB-9732-4277-A36F-2FB046CCE27DQ37854718-5EF8347F-3970-4C07-AD0D-2A16F436D9B5Q38266817-2FB71ABD-4BC2-4782-8251-263615BCAB02Q38679742-E2DBC26D-DAA6-4281-A211-04D33A1FB92CQ39006744-B4C5B88B-8CCB-489C-A185-3C655EB03F72Q40140001-2D9C9477-9871-4A14-ADAC-703BEA8B0715Q40266645-2F70B6D0-E92C-4EFA-BB3C-FC24F3E7668DQ40564160-0CC5CC51-6835-4964-B801-6A222DF2C020Q40981795-81FB6E65-1425-43DC-B89A-F2FC18FA08D3Q41130252-55B32972-74F2-47B1-98A6-DD97521785EDQ43550159-C278455C-8A5F-42D3-A985-B0316DED1707
P2860
Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cerebrospinal fluid and plasma ...... s Candida meningoencephalitis.
@en
type
label
Cerebrospinal fluid and plasma ...... s Candida meningoencephalitis.
@en
prefLabel
Cerebrospinal fluid and plasma ...... s Candida meningoencephalitis.
@en
P2093
P2860
P356
P1476
Cerebrospinal fluid and plasma ...... s Candida meningoencephalitis.
@en
P2093
Amy M Kelaher
Christine Mya-San
Diana Mickiene
Heidi A Murray
Johanna E Hughes
John Bacher
Margaret P Cotton
Ruta Petraitiene
Thomas J Walsh
Vidmantas Petraitis
P2860
P304
P356
10.1128/AAC.00674-08
P407
P50
P577
2008-09-08T00:00:00Z